top of page
The latest on cardiometabolic disease and Covid-19
Search
Hydroxychloroquine/Azithromycin combination and QTc, an expert recommendation
Quality of evidence: D- Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment Authors:...
Abderrahim Benmoussa, phD
Apr 14, 20201 min read
6 views
0 comments
D-Dimer associated with severity, a pooled analysis
Quality of evidence: C+ D-dimer is Associated with Severity of Coronavirus Disease 2019: A meta-analysis Authors: Lippi et al. Journal: ...
Abderrahim Benmoussa, phD
Apr 14, 20201 min read
9 views
0 comments
COVID-19 and cardiovascular disease, a narrative review
Quality of evidence: B+ Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease Authors: Clerkin et al. Journal: Circulation...
Abderrahim Benmoussa, phD
Apr 8, 20201 min read
19 views
0 comments
Nomogram for early prediction of risk, a multicenter retrospective study
Quality of evidence: B A Tool to Early Predict Severe 2019-Novel Coronavirus Pneumonia (COVID-19): A Multicenter Study using the Risk...
Abderrahim Benmoussa, phD
Apr 8, 20201 min read
12 views
0 comments
COVID-19 and the cardiovascular system, a review of the literature
Quality of evidence: B+ COVID-19 and the cardiovascular system Authors: Zheng et al. Journal: Nature Reviews Cardiology (2020)...
Abderrahim Benmoussa, phD
Apr 8, 20201 min read
9 views
0 comments
Cardiovascular implications in fatality, a retrospective monocentric study
Quality of evidence: C Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Authors: Guo T...
Abderrahim Benmoussa, phD
Apr 7, 20201 min read
3 views
0 comments
Clinical features associated with fatality, a retrospective cohort study
Quality of evidence: C Clinical characteristics of 113 deceased patients with coronavirus disease 2019: a retrospective study Authors:...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
4 views
0 comments
Anti-inflammatory drugs and severe cases, a review, and expert position from China
Quality of evidence: C+ The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19):...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
4 views
0 comments
CFR and characteristics linked to fatality, a short summary of Italian cases
Quality of evidence: C- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy Authors: Onder G et al...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
1 view
0 comments
Clinical features in severe pediatric patients with COVID-19, An observational study
Quality of evidence: D Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
2 views
0 comments
Liver injury and severe coronavirus infections, a summary of the evidence
Quality of evidence: C+ Liver injury during highly pathogenic human coronavirus infections Authors: Xu L et al. Journal: Liver...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
7 views
0 comments
COVID-19 Risk Factors, a monocentric retrospective cohort study
Quality of evidence: B Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
3 views
0 comments
Comorbidities in COVID-19, a systematic review, and meta-analysis
Quality of evidence: B + Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
2 views
0 comments
Clinical course and risk factors, a retrospective study
Quality of evidence: B- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
5 views
0 comments
Clinical features of Covid-19, a multicentric cohort study
Quality of evidence: B- Clinical Characteristics of Coronavirus Disease 2019 in China Authors: Guan WJ et al Journal: New-England...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
1 view
0 comments
bottom of page